Regen BioPharma, Inc.
RGBP
$0.0548
$0.00479.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.44% | -65.50% | -157.28% | -151.48% | -101.01% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 373.96% | 601.89% | 3,122.22% | 215.91% | -63.91% |
| Total Other Non-Cash Items | -36.16% | -36.16% | -74.15% | -36.05% | 7.39% |
| Change in Net Operating Assets | 571.20% | 454.29% | 88.90% | 94.54% | 99.93% |
| Cash from Operations | -1.47% | -83.36% | -298.56% | -140.71% | -76.88% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 30.60% | -65.18% | -92.17% | 43.08% | 43.08% |
| Total Debt Repaid | 186.01% | 178.49% | -- | -- | -- |
| Issuance of Common Stock | -59.17% | 65.47% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.63% | 15.43% | 134.95% | 525.67% | 370.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -695.83% | -248.45% | -272.35% | 155.39% | 93.47% |